Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Dr. Richard Law, a former Exscientia executive who helped build the company and facilitate its merger with Recursion ...
Top holdings in the Vanguard Consumer Staples ETF ( VDC 1.09%) include retailers like Costco Wholesale and Walmart, every-day ...
Rebelo joined Grey Health New York in December 2023 as executive creative director after spending nearly three-and-a-half years as chief creative officer at McCann Health New Jersey.
Irish Examiner on MSN5d
Irish pharma firms confident despite Trump's threats but experts warn of turbulent timesDonald Trump wants to 'take back' the US component of Ireland's pharma sector which supports 50,000 jobs, generates exports ...
Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...
Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...
Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...
Why Google DeepMind, Perplexity, Khan Academy, Canva, and Salesforce are among Fast Company’s Most Innovative Companies for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback